期刊文献+

死亡相关蛋白激酶基因启动子甲基化特异性PCR法的建立与初步应用 被引量:2

Establishment and preliminary applification of methylation-specific PCR for detecting methylation of death-associated protein kinase promoter
下载PDF
导出
摘要 目的:建立甲基化特异性PCR(MSP)技术检测死亡相关蛋白激酶(DAPK)基因启动子甲基化。方法:设计针对DAPK基因启动子的MSP引物,建立MSP检测体系对甲基化阳性模板进行检测,评价其特异性、重复性和灵敏性,并经测序鉴定。结果:所建立的甲基化MSP方法仅能扩增出甲基化阳性模板,不能扩增出未甲基化阳性模板和未硫化处理的DNA模板;对不同梯度稀释的甲基化阳性模板进行检测,其最大敏感性可达2%;在不同时间进行甲基化MSP检测的结果均一致。结论:成功建立的DAPK基因启动子甲基化MSP检测方法具有良好的特异性、灵敏性和重复性,可用于肿瘤标本的批量检测。 Objective: To establish the methylation-specific PCR(MSP) for the detection of promoter methylation of death-associated protein kinase(DAPK) gene.Methods: The primers of MSP aiming at the DAPK promoter were designed.MSP was established to detect the methylation positive DNA templates.The specificity,sensibility and repeatability were evaluated. Results: The established methylated MSP could only amplify the methylation positive DNA template,but not the unmethylated DNA template and unmodified DNA template.In a series of dilution,methylated MSP could detect 2% methylation positive DNA templates.The amplified results of same sample were identical on different time. Conclusion: The methylated MSP technique for detecting of DAPK methylation was established successfully and can be used for analyzing samples from cancer patients.
出处 《江苏大学学报(医学版)》 CAS 2009年第1期23-26,共4页 Journal of Jiangsu University:Medicine Edition
基金 江苏省医学重点人才资助项目(RC2007035) 江苏大学临床医学科技发展基金资助项目(JLY20080048) 镇江市社会发展基金资助项目(SH2006032)
关键词 死亡相关蛋白激酶 甲基化特异性PCR 甲基化 death-associated protein kinase methylation-specific PCR methylation
  • 相关文献

参考文献10

  • 1Raveh T,Droguett G, Horwitz MS, et al. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation [ J ]. Nat Cell Biol, 2001,3(1) :1 -7.
  • 2Voso MT,Gumiero D, D'Alo' F, et al. DAP-kinase hypermethylation in the bone marrow of patients with follic-ular lymphoma[J]. Haematologica, 2006, 91 (9) : 1252 - 1256.
  • 3Nakamichi I,Tomita Y, Zhang B, et al. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma [ J ]. Ann Hematol, 2007,86 ( 8 ) :557 - 564.
  • 4Voso MT, Scardocci A, Guidi F, et al. Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes[J]. Blood, 2004, 103(2) :698 -700.
  • 5Chim CS, Fung TK, Wong KF, et al. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia[J]. J Hum Genet, 2006, 51 (9) :832 - 838.
  • 6Hoon DS, Spugnardi M, Kuo C, et al. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients [ J ]. Oncogene, 2004, 23 (22) :4014 - 4022.
  • 7Heisler LE,Torti D, Boutros PC, et al. CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome [ J ]. Nucleic Acids Res, 2005,33 (9) : 2952 - 2961.
  • 8卢志顺,余晓,唐俊利,钱民章.胆固醇对血管内皮细胞基因组DNA甲基化的影响[J].江苏大学学报(医学版),2007,17(1):61-62. 被引量:2
  • 9Herman JG, Graff JR, Myfihanen S, et al. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands [ J ]. Proc Natl Acad Sci USA, 1996,93 (18) :9821 -9826.
  • 10Brandes JC, Carraway H, Herman JG. Optimal primer design using the novel primer design program: MSP primer provides accurate methylation analysis of the ATM promoter[ J ]. Oneogene, 2007,26 (42) : 6229 - 6237.

二级参考文献6

共引文献1

同被引文献13

  • 1刘文斌,吕愈敏,杨雪玲,金珠.粪便钙卫蛋白对溃疡性结肠炎活动性判断价值的研究[J].中华消化杂志,2005,25(7):394-397. 被引量:19
  • 2房殿春,许同铭,赵晶京.Barrett食管诊治共识(草案,2005,重庆)[J].中华消化杂志,2006,26(2):138-139. 被引量:53
  • 3冯景,周有利,张吉才,陶建蜀.甲基化特异性PCR全程易出现的问题与控制措施[J].检验医学,2006,21(4):437-438. 被引量:4
  • 4Quina AS, Buschbeck M, Di Croce L. Chromatin structure and epigenetics [ J ]. Biochem Pharmacol, 2006,72 ( 11 ) : 1563 - 1569.
  • 5Shen L,Kondo Y, Guo Y, et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters [ J ]. PLoS Genet, 2007,3 (10) :2023 - 2036.
  • 6Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation [ J ]. N Engl J Med, 2003, 349(21 ) :2042 -2054.
  • 7Brandes JC, Carraway H, Herman JG. Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter [ J ]. Oncogene, 2007, 26 ( 42 ) : 6229 - 6237.
  • 8Iliopoulos D,Guler G, Han SY, et al. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer [ J ]. Oncogene, 2005, 24(9) : 1625 - 1633.
  • 9Galm O,Wilop S, Ltiders C, et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia [ J ]. Ann Hematol, 2005, 84 ( 1 ) : 39 - 46.
  • 10Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment [J]. J Natl Cancer Inst, 2005, 97(2) :103 -115.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部